ATG-400

ATG-400 is an investigational transdermal drug delivery system developed by Ategenos Pharmaceuticals for oncology indications. The product utilizes the company's proprietary SmartPatch technology, which is designed to deliver an existing, previously approved branded therapeutic agent through the skin. A distinguishing feature of the ATG-400 system is its integrated real-time adherence monitoring capability, which allows healthcare providers to track patient compliance and ensure the medication is administered as prescribed. By transitioning a systemic therapy to a transdermal route, the system aims to optimize drug levels, improve patient adherence, and potentially reduce side effects associated with oral or injectable administration of oncology treatments.